The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Investigating serum β-HCG as an independent prognostic factor in patients (pts) receiving chemotherapy (Ct) for transitional cell carcinoma (TCC) of the urothelial tract.
Simon J. Crabb
No relevant relationships to disclose
Adam Sharp
No relevant relationships to disclose
Julia Head
No relevant relationships to disclose
Caroline Chau
No relevant relationships to disclose
Matthew Wheater
No relevant relationships to disclose
Thomas R. Geldart
No relevant relationships to disclose
Graham Mead
No relevant relationships to disclose